An Observational Registry of Abatacept in Patients with JIA

• Research type

  Research Study

• Full title

  An Observational Registry of Abatacept in Patients with Juvenile Idiopathic Arthritis

• IRAS ID

  166596

• Contact name

  Athimalaipet Ramanan

• Contact email

  avramanan@hotmail.com

• Sponsor organisation

  Bristol-Myers Squibb

• Clinicaltrials.gov Identifier

  NCT01357668

• Duration of Study in the UK

  10 years, 0 months, 1 days

• Research summary

  The short-term safety of abatacept when used in juvenile idiopathic arthritis (JIA) has been previously demonstrated; however, the long-term safety of abatacept has not been well studied. Thus, as part of regulatory requirements, an international registry with long-term follow-up will be established to characterize and evaluate the safety of abatacept.

• REC name

  West Midlands - Edgbaston Research Ethics Committee

• REC reference

  14/WM/1271

• Date of REC Opinion

  18 Dec 2014

• REC opinion

  Unfavourable Opinion